Market Place
Sourcing Support
Veltassa Approved In Japan For Adult Hyperkalemia Treatment
23 Sep 2024 //
PR NEWSWIRE
Vifor`s hyperkalaemia drug Veltassa shows benefit in heart failure patients
21 Dec 2021 //
BUSINESSWIRE
Vifor reports positive outcome of the phase-IIIb DIAMOND trial of Veltassa
20 Dec 2021 //
BUSINESSWIRE
Vifor`s Ferinject® granted new recommendations in ESC heart failure guidelines
31 Aug 2021 //
BUSINESSWIRE
NICE reverses previous decision to recommend Vifor Pharma`s Veltassa for NHS
16 Dec 2019 //
PHARMAFILE
Vifor Pharma’s Phase-II AMBER Study Meets Primary Endpoint
13 May 2019 //
BUSINESSWIRE
Vifor Pharma’s Phase-II AMBER Study Meets Primary Endpoint
10 May 2019 //
BUSINESSWIRE
NICE turns down hyperkalaemia therapies
30 Oct 2018 //
PHARMA TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.